Breaking News
February 23, 2019 - Study gives a snapshot of crocodile evolution
February 23, 2019 - Research finds steep rise in self-poisonings among young people
February 23, 2019 - American Gastroenterological Association announces “AGA Future Leaders Program”
February 23, 2019 - Scientists uncover new mechanisms regulating neural stem cells
February 23, 2019 - Combinations of certain insecticides turn out to be lethal for honeybees
February 23, 2019 - AHA News: Why Are Black Women at Higher Risk of Dying From Pregnancy Complications?
February 23, 2019 - NIMH » Anxiety Disorders
February 23, 2019 - Autistic people urgently need access to tailored mental health support
February 23, 2019 - Newly designed molecule could benefit people with Friedrich’s Ataxia
February 23, 2019 - Chinese CRISPR twins may have better cognition and memory
February 23, 2019 - Study finds new genetic clues associated with asthma in African ancestry populations
February 23, 2019 - Fetal signaling pathways may offer future opportunities to treat lung damage
February 23, 2019 - Early-stage osteoarthritis drug wins prestigious innovation award
February 23, 2019 - Researchers report positive findings with dasotraline for ADHD in children ages 6-12
February 23, 2019 - News study reanalyzes the effects of noncaloric sweeteners on gut microbiota
February 23, 2019 - New device allows scientists to reproduce blow effects on the heart in lab
February 23, 2019 - Holy herb identified as a potential treatment for Alzheimer’s disease
February 23, 2019 - New technology platform digitally counts growth factors in single cells
February 23, 2019 - Surgery and other treatments offer viable options for adult scoliosis
February 23, 2019 - Reduced antibody adaptability may make the elderly more vulnerable to influenza
February 23, 2019 - Neighborhood income, education associated with risk of disability progression in MS patients
February 23, 2019 - 2019 guidelines for management of patients with atrial fibrillation
February 23, 2019 - Surprise rheumatoid arthritis discovery points to new treatment for joint inflammation
February 23, 2019 - A just-right fix for a tiny heart
February 23, 2019 - UMass Amherst scientist explores role of citrus peel in decreasing gut inflammation
February 23, 2019 - Owlstone Medical and Shanghai Renji Hospital collaborate to initiate breath biopsy lung cancer trial
February 23, 2019 - AMSBIO’s comprehensive portfolio of knock-out cell lines and lysates
February 23, 2019 - New app reliably determines physicians’ skills in forming accurate, efficient diagnoses
February 23, 2019 - Peripheral nerve injury can trigger the onset and spread of ALS, shows study
February 23, 2019 - Researchers uncover mechanisms that prevent tooth replacement in mice
February 23, 2019 - Once-a-day capsule offers new way to reduce symptoms of chronic breathlessness
February 23, 2019 - FDA Adds Boxed Warning for Increased Risk of Death with Gout Medicine Uloric (febuxostat)
February 23, 2019 - Phone-based intervention aids rheumatoid arthritis care
February 23, 2019 - Opioid epidemic makes eastern inroads and targets African-Americans
February 23, 2019 - New identified biomarker predicts patients who might benefit from HER2-targeted agents
February 23, 2019 - Study offers new insights into mechanisms of changes in erythrocytes under stress
February 23, 2019 - Antipsychotic polypharmacy may be beneficial for schizophrenia patients
February 23, 2019 - Researchers investigate how marijuana and tobacco co-use affects quit attempts by smokers
February 23, 2019 - Patients with diabetes mellitus have high risk of stable ischemic heart disease
February 23, 2019 - Transparency on healthcare prices played key role in Arizona health system’s turnaround
February 23, 2019 - A comprehensive, multinational review of peppers around the world
February 23, 2019 - Study finds modest decrease in burnout among physicians
February 23, 2019 - A simple change can drastically reduce unnecessary tests for urinary tract infections
February 23, 2019 - Deep Learning-Enhanced Device Detects Diabetic Retinopathy
February 23, 2019 - Researchers discover new binding partner for amyloid precursor protein
February 23, 2019 - Modest decrease seen in burnout among physicians, researchers say | News Center
February 23, 2019 - Transplanting bone marrow of young mice into old mice prevents cognitive decline
February 23, 2019 - Mogrify to accelerate novel IP and cell therapies using $3.7m USD funding
February 23, 2019 - Johns Hopkins study describes cells that may help speed bone repair
February 23, 2019 - Scientists demonstrate influence of food odors on proteostasis
February 23, 2019 - Researchers unlock the secret behind reproduction of fish called ‘Mary’
February 23, 2019 - Acupuncture Could Help Ease Menopausal Symptoms
February 23, 2019 - Researchers use AI to detect early signs of Alzheimer’s
February 23, 2019 - On recovery, vulnerability and ritual: An exhibit in white | News Center
February 23, 2019 - Memory Stored in Unexpected Region of the Brain
February 23, 2019 - Several health experts worldwide gather at EUDONORGAN event
February 23, 2019 - Discovery of potent compound in native California shrub may lead to treatment for Alzheimer’s
February 22, 2019 - Researchers create new map of the brain’s own immune system
February 22, 2019 - ICHE’s reviews on surgical infections, unnecessary urine tests, and nurses’ role in antibiotic stewardship
February 22, 2019 - UK Research and Innovation invests £200 million to create new generation of AI leaders
February 22, 2019 - Takeda collaboration to boost fight against Alzheimer’s and other neurodegenerative diseases
February 22, 2019 - Heavy drinking may change DNA, leading to increased craving for alcohol
February 22, 2019 - U.S. opioid deaths jump fourfold in 20 years; epidemic shifts to Eastern states | News Center
February 22, 2019 - 5 Questions with William Turner on Diversity in Medicine
February 22, 2019 - HHS Finalizes Rule Seeking To Expel Planned Parenthood From Family Planning Program
February 22, 2019 - Researchers uncover biochemical pathway that may help identify drugs to treat Alzheimer’s
February 22, 2019 - Biologist uses new grant to find ways to eliminate schistosomiasis
February 22, 2019 - Bag-mask ventilation to help patients breathe during intubation prevents complications
February 22, 2019 - AbbVie Announces New Drug Application Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
February 22, 2019 - Nature versus nurture and addiction
February 22, 2019 - New website connects researchers with data experts, resources | News Center
February 22, 2019 - Today’s Concerns About Drug Prices Echo The Past
February 22, 2019 - CT and Doppler equipment have low accuracy in detecting cerebral vasospasm and ischemia
February 22, 2019 - Study finds out similarity in function between healthy retina cell and tumor cell
February 22, 2019 - CWRU awarded NIH grant to identify effective treatments for intimate partner violence
February 22, 2019 - Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer
February 22, 2019 - Scientists discover new type of immune cells that are essential for forming heart valves
February 22, 2019 - Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
February 22, 2019 - Genetic defect linked to pediatric liver disease identified
February 22, 2019 - New cellular atlas could provide a deeper insight into blinding diseases
Cholesterol control revised in the latest AHA/ACC guidelines

Cholesterol control revised in the latest AHA/ACC guidelines

image_pdfDownload PDFimage_print

The American Heart Association and the American College of Cardiology have released their latest 121 page guidelines on risk assessment and management of high cholesterol for people who are at a greater risk of heart attacks or strokes.

The recommendations titled, “AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guidelines on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines,” took 18 months for their guidelines to be prepared.

Cholesterol formation, fat, artery, vein, heart. Narrowing of a vein for fat formation. 3d rendering. Image Credit: Naeblys / Shutterstock

Cholesterol formation, fat, artery, vein, heart. Narrowing of a vein for fat formation. 3d rendering. Image Credit: Naeblys / Shutterstock

The last such guidelines were released in 2013 by the AHA/ACC and the group has said that the new recommendations focus on very low levels of LDL cholesterol as being beneficial. LDL cholesterol or “bad” cholesterol is known to contribute to plaque build up in the arteries and results in their narrowing. This raises the risk of heart attacks and strokes.

The latest recommendations were released last Saturday (10th November 2018) at their annual meeting in Chicago. The guidelines emphasizes on a healthy diet and regular exercise as the mainstay of keeping heart disease away. Heart disease, it states, is the leading killer in the US and all steps must be taken to prevent it.

The guidelines state that initial approach to raised cholesterol is changes in lifestyle following which, if uncontrolled, drugs are added. Statins are the staple cholesterol-lowering drugs and are safe and effective in reducing heart disease risk. These guidelines state that among people who have had a heart attack or a stroke, mere statins alone is not enough. Newer cholesterol lowering drugs need to be added to their daily regimen.

The recommendations suggest statins in cases of;

  • No history of heart attacks or stroke and non-diabetic but LDL-C 70 mg/dL or higher and 7.5% or greater 10-year risk by the calculator
  • No history fo heart attacks or strokes but diabetic and LDL-C of 70 mg/dL or greater
  • History of heart attacks or strokes but no heart failure
  • LDL cholesterol ≥190 mg/dL or familial hypercholesterolemia.

According to the new guidelines those at a greater risk need to be administered statins in combination with ezetimibe. It works by lowering the absorption of cholesterol from the gut. For individuals who have very high levels of cholesterol or have a genetic risk of high cholesterol, two newer drugs are recommended. These are called proprotein convertase subtilisin/kexin type 9 or PCSK9 inhibitors. ;Two of the PCSK9 inhibitors available are Amgen Inc’s Evolocumab or Repatha and Regeneron Pharmaceuticals and Sanofi SA’s ; Alirocumab or Praluent. These were launched in 2015 and cost around $14,000 annually. The cost of these two agents has limited their use till date but they have been known to significantly lower cholesterol levels. To improve their uptake by the medical practitioners as well as by the health insurers, their prices have been slashed this year with Repatha at around $5,850 and Praluent at $4,500 – $6,600 annually.

The latest guidelines also include the earlier used calculator that can predict a person’s risk of heart disease over 10 years. Some of the risk factors re-emphasized include smoking, high blood pressure, family history of heart disease, ethnicity and race, premature menopause and presence of chronic kidney disease. Cholesterol testing is recommended from the age of 2 years among children with a family history of high cholesterol. Other children who do not have a family history of cholesterol need to be tested between ages 9 and 11 years. Coronary artery calcium (CAC) levels should be measured among individuals whose risk levels cannot be stratified say the authors.

The guidelines backed by 10 other medical societies and organizations is published in the Journal of the American College of Cardiology and in Circulation. The team was chaired by Scott M. Grundy, University of Texas Southwestern Medical Center at Dallas, and co-chaired by Neil J. Stone, Northwestern University, Chicago, Illinois.

Source:

https://www.ahajournals.org/doi/10.1161/CIR.0000000000000625

About author

Related Articles